Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateWages, Salaries and Other
Others
Ratios

Journey Medical (DERM) Other Operating Expenses (2020 - 2025)

Journey Medical's Other Operating Expenses history spans 6 years, with the latest figure at $6.5 million for Q4 2025.

  • For the quarter ending Q4 2025, Other Operating Expenses rose 487.09% year-over-year to $6.5 million, compared with a TTM value of $25.2 million through Dec 2025, up 27.5%, and an annual FY2025 reading of $25.2 million, up 27.5% over the prior year.
  • Other Operating Expenses for Q4 2025 was $6.5 million at Journey Medical, down from $6.8 million in the prior quarter.
  • The five-year high for Other Operating Expenses was $21.2 million in Q2 2021, with the low at $1.1 million in Q4 2024.
  • Average Other Operating Expenses over 5 years is $8.0 million, with a median of $6.7 million recorded in 2024.
  • Year-over-year, Other Operating Expenses surged 515.06% in 2021 and then tumbled 81.58% in 2024.
  • Tracing DERM's Other Operating Expenses over 5 years: stood at $9.5 million in 2021, then decreased by 18.97% to $7.7 million in 2022, then decreased by 22.07% to $6.0 million in 2023, then tumbled by 81.58% to $1.1 million in 2024, then soared by 487.09% to $6.5 million in 2025.
  • Per Business Quant, the three most recent readings for DERM's Other Operating Expenses are $6.5 million (Q4 2025), $6.8 million (Q3 2025), and $6.0 million (Q2 2025).